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Background: A growing body of scientific research is suggesting that end-of-life care and decision making may
differ between age groups and that elderly patients may be the most vulnerable to exclusion of due care at the
end of life. This study investigates age-related disparities in the rate of end-of-life decisions with a possible or
certain life shortening effect (ELDs) and in the preceding decision making process in Flanders, Belgium in 2007,
where euthanasia was legalised in 2002. Comparing with data from an identical survey in 1998 we also study the
plausibility of the ‘slippery slope’ hypothesis which predicts a rise in the rate of administration of life ending drugs
without patient request, especially among elderly patients, in countries where euthanasia is legal.
Method: We performed a post-mortem survey among physicians certifying a large representative sample (n = 6927)
of death certificates in 2007, identical to a 1998 survey. Response rate was 58.4%.
Results: While the rates of non-treatment decisions (NTD) and administration of life ending drugs without explicit
request (LAWER) did not differ between age groups, the use of intensified alleviation of pain and symptoms (APS)
and euthanasia/assisted suicide (EAS), as well as the proportion of euthanasia requests granted, was bivariately
and negatively associated with patient age. Multivariate analysis showed no significant effects of age on ELD rates.
Older patients were less often included in decision making for APS and more often deemed lacking in capacity
than were younger patients. Comparison with 1998 showed a decrease in the rate of LAWER in all age groups
except in the 80+ age group where the rate was stagnant.
Conclusion: Age is not a determining factor in the rate of end-of-life decisions, but is in decision making as patient
inclusion rates decrease with old age. Our results suggest there is a need to focus advance care planning initiatives
on elderly patients. The slippery slope hypothesis cannot be confirmed either in general or among older people,
as since the euthanasia law fewer LAWER cases were found.
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Life expectancy in developed countries has risen consid-
erably during the last century [1,2]. This has had a pro-
found impact on the age distribution of populations: the
number and proportion of elderly people is steadily ris-
ing and is projected to increase further. The ‘baby boom
generation’ born after WWII is reaching old age. The
proportion of elderly people among decedents is also ris-
ing; in Belgium (Flanders) the proportion of those dying
aged 80 or over has recently reached 50% [3].
As death nowadays mostly follows from chronic and
degenerative disease with a prolonged dying process ra-
ther than from acute infectious disease, care provision in
the end stages of life has become of great interest to
patients, health care workers and national health care
systems. A growing body of scientific literature shows
that provision of end-of-life care can vary between
patients of different ages [4-11]. Older patients have been
reported to have less access to specialist or palliative care
and to receive adequate pain and symptom treatment less
often [4,11], to have life-prolonging treatment forgone
more often [8,11-14], to have do not resuscitate and do
not hospitalise orders more often [8,15-17], and to be
excluded from decision making more often [11,18,19].
Also, research has found that physicians and patients’
family are less inclined to continue or intensify end-of-life
treatment in older than in younger patients [4,20,21].
Patients themselves may also base decisions concerning
their treatment partly on whether they have lived a long
and fulfilling life [11,14,20,22]. These findings thus indi-
cate significant differences or inequalities between differ-
ent ages when it comes to end-of-life care and decision
making. This is of great importance to health care policy
makers as it may imply inequitable distribution of scarce
medical resources [15,23].
So, elderly patients are generally viewed as being more
vulnerable to exclusion of due care. Many opponents of
legalised euthanasia warn of a ‘slippery slope’ towards
more unethical practice among vulnerable patient groups
such as older patients. These critics predict a rise in life
ending without explicit request from the patient in gen-
eral, and especially in elderly patient groups, in countries
where euthanasia is legally regulated [24,25].
In this report we investigate age-related disparities in
end-of-life decisions (ELDs) with a possible or certain
life shortening effect in Flanders, Belgium in 2007. The
studied decisions are intensified drug administration for
pain and other symptoms in doses with life shortening
as possible effect, decisions to withdraw or withhold po-
tentially life-prolonging treatment and physician-assisted
dying ie the prescribing, supplying or administering of
lethal drugs (ie euthanasia, physician-assisted suicide
and life ending acts without explicit patient request).
Belgium is one of only three countries in the worldwhere euthanasia is legal (since 2002) under strict condi-
tions [26]. In order to establish whether the ‘slippery
slope’ argument holds true, particularly for the sup-
posedly vulnerable old, data presented from the 2007
survey will be supplemented where necessary with data
from an identical survey conducted in 1998, before the
euthanasia law was passed. We pose the following re-
search questions: 1) are there differences in 2007 in the
incidence of the various end-of-life decisions across age
groups 2) what are the incidence shifts between 1998 and
2007 in the different age groups 3) what is the preceding
decision making process and 4) does the formulation and
granting of euthanasia requests differ in incidence across
age groups.
Method
Study design
We performed a death certificate survey in Flanders, the
Flemish-speaking half of Belgium which has about six
million inhabitants and approximately 55,000 deaths per
year. This study was identical to a study performed in
1998 [27]. A stratified random sample of deaths was
drawn by the central administration authority for death
certificates, the Flemish Agency for Care and Health. All
deaths between June 1st 2007 and November 30th 2007
of Belgian residents aged one year or older were first
assigned to one of four strata based on the underlying
cause of death, as indicated on the death certificate, and
the estimated corresponding likelihood of an end-of-life
decision. Sampling fractions for each stratum increased
with this likelihood. Such disproportionate sampling was
not done in 1998. This resulted in a sample of 6,927
deaths, about 25% of all deaths in the studied months
and about 12% of all deaths in 2007.
Every certifying physician was sent a five-page ques-
tionnaire for a maximum of five cases, with at most three
reminders in cases of non-response. A lawyer was
involved in the mailing procedure as intermediary be-
tween responding physicians, researchers and the Flem-
ish Agency for Care and Health to guarantee that
completed questionnaires could never be linked to a par-
ticular patient or physician. Only coded patient informa-
tion from the death certificates was linked to the
corresponding completed questionnaires. By guarantee-
ing anonymity for physicians the potential risk of social
desirability bias was decreased. After data collection a
one-page questionnaire was mailed to all non-responding
physicians asking for the reasons for not participating.
The study design, sampling and mailing procedure are
described in detail elsewhere [28].
Of the 6,927 questionnaires mailed to physicians in
2007, 3,623 were returned. From the non-response ana-
lyses we found that response was not possible for 725
deaths (because the physician had changed workplace
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cause the patient could not be identified, because the
physician was not the treating physician and did not
know who this was or because the questionnaire had
never reached the physician). The response rate was
58.4% (3,623/6,202 eligible cases). The response rate in
1998 was 48.1% (1925/3999).
Questionnaire
The 2007 questionnaire was identical to the one used in
1998 [27] and was validated through testing by a panel
of physicians. It first asked whether death had been sud-
den and unexpected. If this question was answered nega-
tively (and hence an end-of-life decision prior to death
would not be precluded) the physician was asked
whether he/she had: 1) withheld or withdrawn medical
treatment taking into account (NTD) or explicitly
intending (NTD+) the hastening of the patient’s death 2)
intensified the alleviation of pain and/or other symptoms
with drugs taking into account (APS) or co-intending
(APS+) the possible hastening of death and 3) adminis-
tered, supplied, or prescribed drugs with the explicit
intention of hastening death. If in the latter case the
drugs had been administered by someone other than the
patient at the patient’s explicit request or prescribed/
supplied and self-administered, it was classified as eu-
thanasia or physician-assisted suicide (EAS). If there had
been no explicit request from the patient, the act was
classified as a life ending act – by administration of
drugs – without explicit patient request (LAWER). An
end-of-life decision is thus defined as a medical decision
at the end of a patient’s life that has a potential or cer-
tain life shortening effect.
In many cases more than one end-of-life decision can
be made in relation to the same patient. Because asking
the same questions about the decision making process
preceding every ELD made would overburden the re-
spondent, we asked only about decision making exclu-
sively for the most important decision. We defined this
as the decision with the most explicit life shortening
intention and in case of two decisions with similar life
shortening intention, administering drugs prevailed over
withholding or withdrawing treatment. Questions about
the preceding decision making process were: whether
the decision had been discussed with the patient, family
and other professional caregivers and whether there had
been a request by the patient. If no discussion had taken
place with the patient, physicians were asked whether
the patient was deemed lacking in capacity and whether
the patient had ever, implicitly or explicitly, expressed a
wish for life ending. The questionnaire also asked about
the reasons for coming to the most important decision.
Independently of whether an end-of-life decision had
been made, an additional question was posed whetherthe patient had made a request for euthanasia that had
not been granted and if so, for what reasons. Demo-
graphic and clinical patient data were obtained from the
death certificates, and linked anonymously after data
collection.
Analysis
The response samples were corrected for disproportion-
ate stratification (2007) and adjusted to be representative
of all deaths for each year (1998 and 2007) for age, sex,
place and cause of death. We selected the non-sudden
deaths as denominator in all analyses. Euthanasia and
assisted suicide were grouped together given that there
were only five assisted suicide cases. For incidence esti-
mates and comparison of estimates between 1998 and
2007, all ELDs made in each patient were included in
the analysis. The most important ELD was taken into ac-
count in the analysis of the decision making process be-
cause questions about decision making were only posed
for the most important ELD. Bivariate percentages were
calculated and logistic regressions were performed to de-
termine bivariate and multivariate p-values (age entered
as categorical variable). A p-value of <0.05 is considered
to indicate statistical significance. All statistical analyses
were done using SPSS 17.0.
Results
Socio-demographic and clinical characteristics
In Flanders, Belgium in 2007 68.1% of deaths were
deemed non-sudden and expected (data not shown).
Decedents older than 80 years are more often female,
widowed and with lower levels of education than are
younger decedents (Table 1). They are also more likely
to die in a care home as opposed to in hospital and less
often from cancer than their younger counterparts. In-
stead, death at old age is associated with more cardio-
vascular and respiratory disease.
Incidence of ELDs in 2007 and comparison with 1998
In Table 2 the incidence of the various ELDs across age
groups is given. For intensified alleviation of pain and
symptoms (APS) a decrease in incidence with age is no-
ticeable in bivariate analysis (p > .001). There is also a
negative association with age (p = .017) in relation to
pain and symptom alleviation with life shortening co-
intention (APS+). The associations disappear however in
multivariate analysis under the influence of cause of
death (not in table). Non-treatment decision (NTD) inci-
dence in 2007 remains relatively stable across age groups
at a little over 50% and no significant association with
age is found. The same applies when life shortening is
explicitly intended (NTD+). For euthanasia and assisted
suicide (EAS) we see a bivariately significant decrease in
rate with increasing age, but this does not hold in
Table 1 Socio-demographic and clinical characteristics of
non-sudden deaths 2007 (weighted %)
Age (yrs) p-value (Chi²)
Total −65 65-79 80+
N (unweighted) 2729 550 972 1207
% In sample (weighted) 100 15,8 32,5 51,7
Sex <0,001
male 47,3 54,5 59,4 37,6
female 52,7 45,5 40,6 62,4
Marital status <0,001
married 46,3 67,0 62,1 30,0
unmarried/divorced 14,3 28,1 14,4 10,0
widowed 39,4 4,9 23,4 60,0
Education <0,001
none or primary 36,0 15,2 31,6 45,1
lower secondary 18,5 20,6 23,7 14,6
higher secondary/higher 17,8 38,3 19,6 10,5
unknown 27,6 26,0 25,1 29,8
Cause of death <0,001
cancer 35,4 63,2 46,4 20,1
cardiovascular 29,2 15,2 20,7 38,7
respiratory 12,0 4,6 11,6 14,5
neurological 4,1 3,6 4,7 3,9
other 19,3 13,4 16,5 22,8
Place of death <0,001
hospital 51,2 62,6 60,3 41,9
at home 20,9 30,7 24,7 15,5
care home 25,2 1,5 12,1 40,6
other 2,8 5,2 2,9 2,0
Table 2 ELD incidence 2007 by age groups, non-sudden deat
Patient age (yrs)
−45 45-64 65-69 70-74 75-79
n= 76 n=474 n=217 n=293 n=46
APS 74,4 61,5 59,0 62,8 50,4
APS+ 18,6 13,4 13,1 15,5 12,4
NTD 54,4 53,8 53,2 56,6 50,1
NTD+ 21,1 18,7 19,8 17,9 21,0
EAS 6,2 6,8 4,8 4,5 3,0
LAWER 2,8 1,2 3,8 3,0 3,0
Unweighted number of cases, weighted percentages.
*p-values calculated by logistic regression (age entered as categorical variable). Mu
of death (no interaction effects); educational attainment not featured in multivariat
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; A
shortening; NTD: non-treatment decisions; NTD+: non-treatment decisions explicitly
LAWER: life ending acts without explicit patient request.
Chambaere et al. BMC Public Health 2012, 12:447 Page 4 of 10
http://www.biomedcentral.com/1471-2458/12/447multivariate analysis on the count of cause and place of
death (not in table). Lastly, the incidence of life ending
without explicit patient request (LAWER) is not asso-
ciated with age and amounts to 1.2% and 3.8% of non-
sudden deaths.
Figure 1 presents the Table 2 percentages graphically,
supplemented by 1998 data, and Table 3 shows the
multivariate odds ratios for the various ELDs by age
groups between 1998 and 2007. Intensified alleviation of
pain and symptoms (APS) is consistently more likely to
be performed in 2007 than in 1998, in all age groups.
With life shortening co-intended (APS+) the reverse pic-
ture emerges: this decision is in every age group less
likely in 2007 than in 1998. Non-treatment decisions
(NTD) are more likely in 2007 for the age groups 65–
79 years and 80+ years than in 1998. Decisions not to
treat with an explicit life shortening intention (NTD+)
are less likely in 2007 than in 1998 for the oldest age
group (80+ years). In the age group 65–79 years euthan-
asia and assisted suicide (EAS) are 2.4 times more likely
to occur in 2007 than in 1998; for other age groups the
odds ratio is not statistically significant. As concerns life
ending acts without explicit request (LAWER), patients
younger than 65 years were 5.9 times less likely to
undergo this decision in 2007 than in 1998 and patients
aged 65–79 1.9 times less likely. Patients aged 80 or over
did not have a significantly different chance of life end-
ing without request than in 1998.Decision making process of ELDs
Concerning the process of decision making where inten-
sified alleviation of pain and other symptoms (APS) was
the most important decision, younger patients are more
often included in the discussion and more often formu-
late an explicit request than do older patients (Table 4).hs (weighted %)
p-value*
80-84 85-89 90+ biv. multiv.
2 n = 483 n= 391 n= 333
50,5 46,7 46,5 <0.001 0.119
12,5 9,6 6,8 0.017 0.504
52,4 50,1 51,7 0.800 0.761
15,9 15,9 13,0 0.107 0.215
2,5 0,5 0,1 <0.001 0.359
3,1 3,4 1,5 0.435 0.671
ltivariate regression with confounders sex, marital status, cause of death, place
e model due to the large number of missings.
PS+: intensified alleviation of pain and other symptoms co-intending life
intending life shortening; EAS: euthanasia and physician-assisted suicide;
Figure 1 ELD rates 1998–2007 by age groups, non-sudden deaths (weighted %)..
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and request rate remains significant after multivariate
controlling for confounders. The same multivariate asso-
ciation is found in discussion with the patient about in-
tensifying pain and symptom treatment with life
shortening co-intention (APS+): 70% of patients younger
than 65 years are included compared with 19% of
patients older than 80 years. Also, for intensified painTable 3 Multivariate ORs (95% CI) 2007 vs. 1998 for ELD incid
Patient age (yr
−65 65-79
APS 1,46 (1,01-2,11) 1,57 (1,23-2,01
APS+ 0,45 (0,29-0,69) 0,71 (0,51-0,97
NTD 1,25 (0,88-1,76) 1,40 (1,11-1,77
NTD+ 0,74 (0,49-1,14) 0,91 (0,68-1,21
EAS 1,63 (0,72-3,72) 2,42 (1,04-5,65
LAWER 0,17 (0,06-0,47) 0,52 (0,30-0,93
*1998 is the reference year. Odds ratios (ORs) and 95% confidence intervals (CI) in b
(multivariate logistic regression with confounders sex, marital status, cause of death
multivariate model due to the large number of missings).
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; A
shortening; NTD: non-treatment decisions; NTD+: non-treatment decisions explicitly
LAWER: life ending acts without explicit patient request.and symptom treatment older patients were more often
deemed lacking in capacity. For all other end-of-life
decisions the proportion of patients lacking in capacity
did not differ significantly across age groups, though a
higher rate of incompetence is found in older patient
groups. Palliative care (PC) specialists were more often
consulted in relation to younger patients than to the old-
est patients for intensified pain and symptom alleviation.ences by age groups (weighted)*
s) all ages
80+
) 1,83 (1,49-2,25) 1,66 (1,44-1,91)
) 0,70 (0,52-0,95) 0,64 (0,53-0,78)
) 1,23 (1,01-1,50) 1,30 (1,13-1,49)
) 0,60 (0,47-0,77) 0,73 (0,62-0,87)
) 0,86 (0,36-2,06) 1,60 (0,99-2,58)
) 0,87 (0,49-1,54) 0,56 (0,39-0,79)
old indicate statistically significant differences between 1998 and 2007
, place of death - no interaction effects; educational attainment not featured in
PS+: intensified alleviation of pain and other symptoms co-intending life
intending life shortening; EAS: euthanasia and physician-assisted suicide;
Table 4 Decision making with patient, family and caregivers 2007 by ELD and age groups (weighted %)
Most important ELD APS APS+ NTD NTD+ EAS LAWER
Patient age (yrs) −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+ −65 65-79 80+
N (unweighted) 288 461 500 40 71 55 93 190 285 63 121 138 51 64 27 10 28 28
discussed with patient 41 26 17 70 47 19 25 24 17 27 24 24 100 100 100 33 24 19
discussed and explicit request by patient 29 19 11 57 30 15 11 10 10 14 10 15 100 100 100 0 0 0
not discussed with patient 59 74 84 30 53 81 75 76 83 73 76 76 0 0 0 67 76 81
not discussed and patient not competent 42 58 75 20 45 70 66 73 79 66 75 74 - - - 60 65 74
not discussed but wish stated by patient 8 12 15 5 20 11 9 15 21 9 20 20 - - - 17 23 47
discussed with family 54 60 53 65 72 73 33 36 40 79 73 74 78 81 64 67 76 83
discussed with colleague(s) 43 37 31 57 54 38 63 57 41 76 63 49 85 83 53 67 64 53
discussed with PC specialist 24 27 17 46 44 16 8 15 18 11 20 23 54 60 21 50 12 12
discussed with nurse(s) 28 43 37 44 58 46 42 40 46 44 46 53 58 61 29 50 56 27
Percentages in bold indicate statistically significant differences between age groups after bivariate logistic regression, p < .05.
Underlined percentages indicate statistically significant differences between age groups after multivariate logistic regression controlling for confounders
(sex, marital status, cause of death, place of death - no interaction effects; educational attainment not featured in multivariate model due to the large number of
missings), p < .05.
ELD: end-of-life decision; APS: intensified alleviation of pain and other symptoms; APS+: intensified alleviation of pain and other symptoms co-intending life
shortening; NTD: non-treatment decisions; NTD+: non-treatment decisions explicitly intending life shortening; EAS: euthanasia and physician-assisted suicide;
LAWER: life ending acts without explicit patient request.
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sion of the patient in the discussion or for discussion
with family or other caregivers in non-treatment deci-
sions. The rate of discussion with colleague physicians
was bivariately negatively associated with increasing age,
whereas palliative care (PC) consultation was multivari-
ately positively associated with increasing patient age:
for non-treatment decisions in patients older than
80 years, the rate of PC consultation was 18% whereas
the rate in younger patients was 8%. The rate for NTD+
rises from 11% in patients younger than 65 years to 23%
in those older than 80 years. NTD+ is the only type of
ELD where patients aged 80 or over were significantly
more often included in decision making than in 1998
(not in table).
Euthanasia and assisted suicide are by definition al-
ways discussed with the patient. No multivariate effect
of age on decision making was found for these acts.
Bivariately, a colleague physician is more often consulted
in younger patients receiving euthanasia or assisted sui-
cide (85% and 83%) than in the oldest patients (53%).
There were also no multivariately controlled effects of
age on decision making in life ending without request
but the rate of PC consultation was bivariately signifi-
cantly higher among patient under 65 years (50%) than
among patients over 65 years (12%).
Granting or rejecting euthanasia requests
In 1998 younger patients tended to formulate a request
for euthanasia more often than older patients but this
finding was not significant after multivariate testing
(Table 5). Also, the proportion of requests for euthanasia
that were granted did not differ significantly betweenage groups. In 2007 the rate of euthanasia requests did
differ significantly between age groups: the rate was
10.3% for patients younger than 65 years, 5.6% for
patients aged 65 to 79 and 2.6% for patients aged 80 or
older. Patients younger than 80 years were significantly
more likely to see their request granted than those in
the oldest patient group but this association did not hold
after multivariate testing (principal confounder: cause
of death). When examining the reasons for granting a
euthanasia request, physicians indicated that ‘life
should not be prolonged needlessly’ more often when it
concerned older patients (p = 0.016). This finding proved
insignificant in multivariate analysis with other confoun-
ders (p = 0.066). Physicians indicated having their own
objections in principle as a relevant reason for rejecting
a euthanasia request more often with the oldest patients
(in 22%), but this significant association also disappeared
after multivariate testing.
Discussion
This study found a number of differences between age
groups in end-of-life decision making. In 2007 the inci-
dence of intensified pain and symptom treatment and
also of euthanasia and assisted suicide decreased signifi-
cantly with increasing age, but not after multivariate
testing with a number of confounders. Comparing 2007
with 1998, decisions to intensify alleviation of pain and
symptoms, not to treat, and to perform euthanasia or
assisted suicide were more likely to have been made for
intensified pain and symptom alleviation in all age
groups, for non-treatment decisions in patients aged 65
or over and for euthanasia and assisted suicide only in
the 65–79 age group. Alleviation of pain and symptoms
Table 5 Granted and rejected euthanasia/assisted suicide (EAS) requests 1998 and 2007 by age groups (weighted %)
Patient age (yrs) p-value*
−65 65-79 80+ biv. multiv.
1998 n= 181 n= 408 n= 640
Request for EAS 7,6 4,6 3,9 0.097 0.326
granted 53 32 35 0.392 0.909
rejected 47 68 65
2007 n= 550 n= 972 n = 1207
Request for EAS 10,3 5,6 2,6 <0.001 0.034
granted 63 64 38 0.039 0.296
rejected 37 36 62
Reasons for granting (n = 51) (n = 64) (n = 27)
no prospect of improvement 92 77 87 0.367 0.715
request/wish of the patient 89 94 100 0.736 0.465
severe symptoms (excl. pain) 81 67 71 0.612 0.803
severe pain 69 57 50 0.508 0.702
loss of dignity 50 57 43 0.751 0.675
low expected life quality 46 61 64 0.379 0.478
expected further suffering 42 57 71 0.239 0.170
life should not be prolonged needlessly 19 45 67 0.016 0.066
request/wish of the family 19 20 50 0.095 0.651
situation unbearable for family 19 16 20 0.916 0.914
Reasons for rejecting (n = 33) (n = 27) (n = 25)
death before request granted 60 47 32 0.230 0.548
patient revoked request 20 12 17 0.808 0.994
no well-considered request 7 11 13 0.823 0.494
fear for legal consequences 7 18 0 0.104 >0.999
suffering was not unbearable 7 0 17 0.155 0.485
principle objections 0 0 22 0.022 0.389
medical condition not hopeless 0 0 13 0.110 0.818
institutional policy 0 0 13 0.110 >0.999
patient was not terminally ill 0 0 4 0.492 >0.999
no voluntary request 0 0 0 >0.999 >0.999
other reason(s) 7 12 9 0.879 0.832
Unweighted number of cases, weighted percentages.
*p-values calculated by logistic regression. Multivariate regression with confounders sex, marital status, cause of death, place of death (no interaction effects);
educational attainment not featured in multivariate model due to the large number of missings.
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in 2007 than in 1998 in all age groups whereas non-
treatment decisions with explicitly intended life shorten-
ing were less likely only for the oldest age group and life
ending without explicit request less likely only for
patients younger than 80 years. As concerns decision
making with the patient in 2007 this was more often
done with younger patients for intensified alleviation of
pain and symptoms. For such decisions a palliative care
specialist was less often involved when the patient was
80 years or older while the opposite was found for non-treatment decisions. Lastly, in 2007 the rate of euthan-
asia requests decreased with increasing age and the old-
est patients saw their request rejected more often,
though this latter finding was not significant after multi-
variate testing.
Though the occurrence of the various ELDs in 2007
was not directly influenced by patient age, we did find a
bivariate (negative) association of age with intensified
pain and symptom alleviation and with euthanasia/
assisted suicide. It is well known that older patients have
different socio-demographic and clinical profiles from
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place of death seemed to be the factors determining the
likelihood of an end-of-life decision. This does not how-
ever mean that there is no problem related to age. The
reality remains that older patients are less likely to re-
ceive intensified pain and symptom treatment in the
context of palliative care, something which is confirmed
by the higher levels of consultation of palliative care
experts for younger patient groups and which is consist-
ent with earlier studies [8,29]. This is probably because
elderly patients die from cancer relatively infrequently
and palliative care is historically provided mainly to can-
cer patients [30-32]as the cancer trajectory is more pre-
dictable [2,30,33]. Generally, policy should aim at taking
away barriers to equality between ages independently of
diagnosis. Patients of all ages should be entitled to the
same intensity and quality of care. If provision of pallia-
tive care is expanded to patients with non-malignant
diagnoses, something which is widely advocated
[30,32,33], the differences between age groups, and spe-
cifically the ‘undertreatment’ of the oldest, should dis-
appear. This is of course assuming that the lower
incidence of pain and symptom alleviation in older
patients is a sign of undertreatment; hypotheses explain-
ing the age disparity in palliative care consumption in-
clude the suggestion that pain and other symptoms are
less often recognised in elderly patients [8,21,34], that
elderly patients are less able to report them [16,33] or
that they have learned to cope with long-term pain
[35,36]. These hypotheses seem to be disproved by our
data; the issue should be investigated more deeply.
As concerns euthanasia and assisted suicide, it is not
possible to make qualitative/moral judgments on the ef-
fect of age on occurrence, which in our multivariate
model was explained by differences between cancer and
non-cancer diagnosis. What we know is that there is
more acceptance of euthanasia among younger genera-
tions [37]. Our finding that older patient groups request
euthanasia less often than do younger groups corrobo-
rates this. This can be related to generational effects and
also to differences in educational attainment [38]. Unfor-
tunately, the latter factor could not be included in the
analysis. It is significant, however, that there is no age-
based difference in the proportion of requests granted.
Our study did find a bivariate relationship ie fewer
requests granted in the 80+ age group than in younger
groups, but this disappeared after multivariate testing
again due to differences between cancer and non-cancer
diagnosis. So it seems that non-cancer patients are less
likely to have their request for euthanasia granted. This
is not problematic per se as the Belgian euthanasia law
prescribes rigorous criteria for eligibility [26], and these
criteria are thought to be less easily confirmed in non-
cancer patients. Indeed, because legal criteria such as‘unbearable suffering’ are so difficult to define in practice,
cancer patients may be viewed as the ‘ideal’ euthanasia pa-
tient against which euthanasia requests from non-cancer
patients are compared and often deemed insufficiently in
accordance with the euthanasia law [39]. However, euthan-
asia among cancer patients may be socially more acceptable
making physicians more reluctant to grant euthanasia to
non-cancer patients. If this is the case then the difference be-
tween the options available to cancer and non-cancer
patients becomes problematic. More research is needed to
elucidate this.
One finding that is not in line with previous research
[8,12,13] is that the incidence of non-treatment deci-
sions does not increase with age; if anything, our ana-
lyses show a tendency towards fewer decisions to forgo
life-sustaining or life-saving treatment as age increases,
particularly where the hastening of death is explicitly
intended. Many studies suggest that considerations of
age may come into play when deciding whether to initi-
ate or continue treatment at the end of life, in surveys of
both attitudes and actual practice [8,11-14]. In Flanders,
Belgium, this phenomenon seems nonexistent or mar-
ginal at most. In past studies in Belgium (and elsewhere)
using the same method we did find age differences in in-
cidence of non-treatment decisions, but this is because
we included only the most important ELD for each case
[3,27]. When analysing cases permitting more than one
ELD per case, we find no age differences in NTD inci-
dence. Further research could study whether different
types of non-treatment decisions (medication, hydra-
tion/nutrition, CPR, respiration, oncotherapy, surgery,
dialysis) have divergent frequencies in various age
groups.
Though age may not be a determining factor in the in-
cidence of end-of-life decisions, it is all the more import-
ant in decision making. The older the patient, the less
often he or she is involved in decision making to inten-
sify pain and symptom alleviation, and the less likely he
or she is to explicitly request it. This confirms the find-
ings of other studies which offer relevant explanatory
hypotheses of lower assertiveness or empowerment and
less aspiration to autonomy in older patients [11,18].
Elderly patients often put all faith in the physician, who
is viewed as the expert as well as the moral authority in
what is perceived as a hierarchical relationship [18,40].
Elderly patients were in our study also more frequently
found to be lacking in capacity to be involved in end-of-
life decision making. As consensus continues to grow
that respecting the patient’s wishes is paramount in
these decisions [14,15,19,32], the need for advance care
planning, or at least an exploration of preferences before
the patient loses capacity is thus very clear, particularly
in the oldest patient groups [2,19,41]. Save for non-
treatment decisions, the inclusion rate of older patients
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since 1998. Additionally, we found no accompanying
higher rate of family inclusion or consultation of collea-
gues or nurses in decision making in older patients than
there had been a decade earlier. It is thus warranted to
conclude that older patients are at higher risk of pater-
nalism. Advance care planning initiatives need to target
the oldest patient population specifically.
What emerges clearly from our findings is that there is
no evidence to support the slippery slope hypothesis
[24,25] in elderly patients, let alone in general. Life end-
ing acts without explicit patient request have not risen
in incidence since the enactment of the euthanasia law;
to the contrary, LAWER incidence has decreased signifi-
cantly since 1998 in the age groups below 80 years
though in the oldest patients the rate has remained the
same. Also elderly patients are not more at risk of
LAWER than younger patients in 2007. Our findings
thus do not confirm the ‘slippery slope’ hypothesis either
in general or in elderly patients. It is, however, note-
worthy that the LAWER rate has remained stagnant
since 1998 in the oldest age group while it is declining
in younger age groups. This may be an indication of per-
sistent paternalism in decision making for elderly
patients, and further argument for focusing advance care
initiatives on the oldest. The development of the inci-
dence of a controversial decision like LAWER in older
patients needs to be closely monitored, as adverse effects
could only become apparent after a longer period of
legalised euthanasia.
There are a number of limitations inherent in this
study. Given the length of time between the death in
question and completing the questionnaire, we cannot
exclude the influence of memory bias in the reporting
physicians. Also, our survey includes only the perspec-
tive of the treating physicians and not those of relatives
or other caregivers. The more than 40% non-response
rate may have generated bias in the results, although the
data were weighted to correct for this. As our study
depends on a conceptualisation of reality, the classifica-
tion scheme of ELDs as approximation may not fully
reflect actual practices and ignore the complexity of
end-of-life decision making. Furthermore, although we
have information on the process of decision making, we
do not know what the discussion outcomes were. Finally,
we could not include in the analyses the patient’s educa-
tional attainment as confounder to age due to the high
proportion of missing cases, although this may be an im-
portant determining factor in end-of-life decision
making.
Conclusion
We conclude that age is not a determining factor in the
rate of end-of-life decisions, but plays a role in thepreceding decision making process. Whereas the rates of
non-treatment decisions and life ending without request
do not differ between age groups, those of intensified
pain and symptom alleviation and euthanasia/assisted
suicide requests do but are determined predominantly
by diagnosis ie cancer/non-cancer. Conversely, patient
involvement in decision making ís determined by patient
age independently of other factors and this suggests the
need for a focus on advance care planning initiatives for
elderly patients. Comparison with data from before Bel-
gian euthanasia regulation yielded no evidence of a ‘slip-
pery slope’ as fewer LAWER cases were reported since
the euthanasia law. Nonetheless this needs to be moni-
tored closely in the future.
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